A randomized trial of 13-Cis retinoic acid in children with advanced neuroblastoma after high-dose therapy

被引：50

作者：

Kohler, JA ^{[1
]}

Imeson, J

Ellershaw, C

Lie, SO

机构：

[1] Southampton Gen Hosp, Southampton SO16 6YD, Hants, England

[2] Univ Leicester, Dept Epidemiol & Publ Hlth, United Kingdom Childrens Canc Study Grp, Leicester LE1 6TP, Leics, England

[3] Natl Hosp Norway, Dept Pediat, N-0027 Oslo, Norway

来源：

BRITISH JOURNAL OF CANCER | 2000年 / 83卷 / 09期

关键词：

13-Cis retinoic acid; neuroblastoma;

D O I：

10.1054/bjoc.2000.1425

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

One hundred and seventy-five children with Stage 3 or 4 neuroblastoma who had obtained a good response to conventional therapy were randomly allocated to 13-Cis retinoic acid at a dose of 0.75 mg/kg/day or placebo for up to 4 years. Toxicity was mild but no advantage in event-free survival was shown for the children receiving retinoic acid. (C) 2000 Cancer Research Campaign.

引用

页码：1124 / 1127

页数：4

共 13 条

[1] INTERNATIONAL CRITERIA FOR DIAGNOSIS, STAGING, AND RESPONSE TO TREATMENT IN PATIENTS WITH NEURO-BLASTOMA [J].

BRODEUR, GM ;

SEEGER, RC ;

BARRETT, A ;

BERTHOLD, F ;

CASTLEBERRY, RP ;

DANGIO, G ;

DEBERNARDI, B ;

EVANS, AE ;

FAVROT, M ;

FREEMAN, AI ;

HAASE, G ;

HARTMANN, O ;

HAYES, FA ;

HELSON, L ;

KEMSHEAD, J ;

LAMPERT, F ;

NINANE, J ;

OHKAWA, H ;

PHILIP, T ;

PINKERTON, CR ;

PRITCHARD, J ;

SAWADA, T ;

SIEGEL, S ;

SMITH, EI ;

TSUCHIDA, Y ;

VOUTE, PA .

JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (12) :1874-1881

[2] 13-CIS-RETINOIC ACID (NSC-122758) IN THE TREATMENT OF CHILDREN WITH METASTATIC NEUROBLASTOMA UNRESPONSIVE TO CONVENTIONAL CHEMOTHERAPY - REPORT FROM THE CHILDRENS-CANCER-STUDY-GROUP [J].

FINKLESTEIN, JZ ;

KRAILO, MD ;

LENARSKY, C ;

LADISCH, S ;

BLAIR, GK ;

REYNOLDS, CP ;

SITARZ, AL ;

HAMMOND, GD .

MEDICAL AND PEDIATRIC ONCOLOGY, 1992, 20 (04) :307-311

[3] USE OF ALL-TRANS RETINOIC ACID IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA [J].

HUANG, ME ;

YE, YC ;

CHEN, SR ;

CHAI, JR ;

LU, JX ;

ZHOA, L ;

GU, LJ ;

WANG, ZY .

BLOOD, 1988, 72 (02) :567-572

[4] PREVENTION OF SKIN-CANCER IN XERODERMA PIGMENTOSUM WITH THE USE OF ORAL ISOTRETINOIN [J].

KRAEMER, KH ;

DIGIOVANNA, JJ ;

MOSHELL, AN ;

TARONE, RE ;

PECK, GL .

NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (25) :1633-1637

[5]

LIPPMAN SM, 1987, CANCER TREAT REP, V71, P391

[6] 9-cis retinoic acid - A better retinoid for the modulation of differentiation, proliferation and gene expression in human neuroblastoma [J].

Lovat, PE ;

Irving, H ;

Malcolm, AJ ;

Pearson, ADJ ;

Redfern, CPF .

JOURNAL OF NEURO-ONCOLOGY, 1997, 31 (1-2) :85-91

[7] Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid [J].

Matthay, KK ;

Villablanca, JG ;

Seeger, RC ;

Stram, DO ;

Harris, RE ;

Ramsay, NK ;

Swift, P ;

Shimada, H ;

Black, CT ;

Brodeur, GM ;

Gerbing, RB ;

Reynolds, CP .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (16) :1165-1173

[8] 9-CIS RETINOIC ACID INDUCES COMPLETE REMISSION BUT DOES NOT REVERSE CLINICALLY ACQUIRED RETINOID RESISTANCE IN ACUTE PROMYELOCYTIC LEUKEMIA [J].

MILLER, WH ;

JAKUBOWSKI, A ;

TONG, WP ;

MILLER, VA ;

RIGAS, JR ;

BENEDETTI, F ;

GILL, GM ;

TRUGLIA, JA ;

ULM, E ;

SHIRLEY, M ;

WARRELL, RP .

BLOOD, 1995, 85 (11) :3021-3027

[9]

Parmar M.K. B., 1995, SURVIVAL ANAL PRACTI

[10] DESIGN AND ANALYSIS OF RANDOMIZED CLINICAL-TRIALS REQUIRING PROLONGED OBSERVATION OF EACH PATIENT .1. INTRODUCTION AND DESIGN [J].

PETO, R ;

PIKE, MC ;

ARMITAGE, P ;

BRESLOW, NE ;

COX, DR ;

HOWARD, SV ;

MANTEL, N ;

MCPHERSON, K ;

PETO, J ;

SMITH, PG .

BRITISH JOURNAL OF CANCER, 1976, 34 (06) :585-612

← 1 2 →